George Harad - Clorox Independent Director
| CLX Stock | USD 143.20 0.86 0.60% |
Director
Mr. George J. Harad is no longer an Independent Chairman of the Board of the Company effective August 16 2016. He was Executive Chairman of the Board of OfficeMax Incorporated formerly known as Boise Cascade Corporation from October 2004 until his retirement in June 2005. He served as Chairman of the Board and Chief Executive Officer of Boise Cascade from April 1995 until October 2004. Previously Mr. Harad held various positions at Boise Cascade including Controller Senior Vice President and Chief Financial Officer and President and Chief Operating Officer. Prior to joining Boise Cascade Mr. Harad was a consultant for the Boston Consulting Group and a teaching fellow at Harvard University. Mr. Harads prior executive leadership roles enable him to provide valuable contributions with respect to management operations strategy growth and longrange plans. His experience as a chief financial officer has provided him with expertise in finance and accounting matters. Additionally as a former chief executive officer of a Fortune 500 company Mr. Harad brings extensive knowledge in executive compensation matters. Mr. Harads long history as a director and deep experience with the Company enable him to bring important leadership perspectives to our Board. since 2015.
| Age | 70 |
| Tenure | 9 years |
| Address | 1221 Broadway, Oakland, CA, United States, 94612-1888 |
| Phone | 510 271 7000 |
| Web | https://www.thecloroxcompany.com |
Clorox Management Efficiency
The company has Return on Asset of 0.0891 % which means that on every $100 spent on assets, it made $0.0891 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2623 %, implying that it generated $0.2623 on every 100 dollars invested. Clorox's management efficiency ratios could be used to measure how well Clorox manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.03 in 2024. Return On Capital Employed is likely to drop to 0.23 in 2024. At this time, Clorox's Non Currrent Assets Other are fairly stable compared to the past year. Intangible Assets is likely to rise to about 852.2 M in 2024, whereas Total Assets are likely to drop slightly above 3.9 B in 2024.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Vittorio Colao | Unilever PLC ADR | 57 | |
| Paul Fribourg | Estee Lauder Companies | 66 | |
| Beth Pritchard | ELF Beauty | 73 | |
| Judith Hartmann | Unilever PLC ADR | 51 | |
| Laura Cha | Unilever PLC ADR | 71 | |
| AnnaLena Kamenetzky | Coty Inc | N/A | |
| Richard Zannino | Estee Lauder Companies | 61 | |
| Louise Fresco | Unilever PLC ADR | 64 | |
| Aerin Lauder | Estee Lauder Companies | 44 | |
| Erhard Schoewel | Coty Inc | 71 | |
| Mary Ma | Unilever PLC ADR | 65 | |
| Jack Stahl | Coty Inc | 61 | |
| Joachim Faber | Coty Inc | 67 | |
| Jennifer Hyman | Estee Lauder Companies | 40 | |
| Lauren Levitan | ELF Beauty | 54 | |
| Adrian Hennah | Unilever PLC ADR | 63 | |
| Barry Sternlicht | Estee Lauder Companies | 59 | |
| William McGlashan | ELF Beauty | 53 | |
| Mellody Hobson | Estee Lauder Companies | 48 | |
| Kirk Perry | ELF Beauty | 53 | |
| Graeme Pitkethly | Unilever PLC ADR | 58 | |
Management Performance
| Return On Equity | 0.26 | ||||
| Return On Asset | 0.0891 |
Clorox Leadership Team
Elected by the shareholders, the Clorox's board of directors comprises two types of representatives: Clorox inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Clorox. The board's role is to monitor Clorox's management team and ensure that shareholders' interests are well served. Clorox's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Clorox's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Stacey Grier, Vice President - Brand Engagement and Enhanced Wellness Marketing | ||
| George Harad, Independent Director | ||
| Andrew Mowery, Senior Vice President Chief Product Supply Officer | ||
| Troy Datcher, Senior Vice President Chief Customer Officer | ||
| Paul Parker, Independent Director | ||
| Denise Garner, Senior Vice President Chief Innovation Officer | ||
| Rick Mcdonald, Senior Vice President Chief Product Supply Officer | ||
| Laura Peck, Chief Financial Officer, Vice President, Controller | ||
| Benno Dorer, Chairman of the Board, Chief Executive Officer | ||
| Kevin Jacobsen, Chief Financial Officer, Executive Vice President | ||
| Laura Stein, Executive Vice President, General Counsel - Corporate Affairs | ||
| Matthew Shattock, Independent Chairman of the Board | ||
| Eric Schwartz, Senior Officer | ||
| John McNulty, Senior Vice President, Chief Information Officer | ||
| Linda Rendle, Executive Vice President - Strategy and Operations | ||
| Jeffrey Noddle, Independent Director | ||
| Amy Banse, Independent Director | ||
| Allan Mackay, Independent Director | ||
| Diego Barral, Senior Vice President General Manager - International Division | ||
| Matthew Laszlo, Senior Vice President Chief Customer Officer | ||
| Jeffrey Baker, Chief Accounting Officer, Corporate Controller | ||
| Lisah Burhan, Managing Director - Investor Relations | ||
| Spencer Fleischer, Independent Director | ||
| Carolyn Ticknor, Independent Director | ||
| James Foster, Senior Vice President Chief Product Supply Officer | ||
| Chau Banks, Senior Vice President, Chief Information and Enterprise Analytics Officer | ||
| Eric Reynolds, Executive Vice President - Cleaning and Burt's Bees | ||
| Nikolaos Vlahos, Senior Vice President Chief Customer Officer | ||
| Kirsten Marriner, Chief People and Corporate Affairs Officer, Executive Vice President | ||
| Pamela Graham, Lead Independent Director | ||
| Rebecca Dunphey, Group Connection | ||
| Michael Costello, Senior Vice President, General Manager - Nutranext and RenewLife | ||
| Manjit Singh, Senior Vice President, Chief Information Officer | ||
| Richard Carmona, Independent Director | ||
| Russell Weiner, Independent Director | ||
| Matt Gregory, Senior Officer | ||
| Jacqueline Kane, Executive VP of HR and Corporate Affairs | ||
| Robert Matschullat, Lead Independent Director | ||
| Angela Hilt, Senior Vice President – Chief Legal Officer | ||
| Christopher Williams, Independent Director | ||
| Stephen Robb, CFO and Executive VP | ||
| Dawn Willoughby, Senior Vice President General Manager - Cleaning Division | ||
| Pamela ThomasGraham, Lead Independent Director | ||
| Tony Matta, Executive Vice President Chief Growth Officer | ||
| Erbie Foster, Chief Officer | ||
| Esther Lee, Independent Director | ||
| William Bailey, Senior Vice President – Corporate Business Development | ||
| Jon Balousek, Senior Vice President General Manager - Specialty Division | ||
| Rogelio Rebolledo, Independent Director | ||
| Kathryn Tesija, Director | ||
| Daphna Coffman, Individual Stockholder Contacts |
Clorox Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Clorox a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.26 | ||||
| Return On Asset | 0.0891 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 20.71 B | ||||
| Shares Outstanding | 124.11 M | ||||
| Shares Owned By Insiders | 0.10 % | ||||
| Shares Owned By Institutions | 81.37 % | ||||
| Number Of Shares Shorted | 3.55 M | ||||
| Price To Earning | 45.43 X |
Pair Trading with Clorox
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Clorox position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clorox will appreciate offsetting losses from the drop in the long position's value.Moving together with Clorox Stock
| 0.68 | EL | Estee Lauder Companies Buyout Trend | PairCorr |
| 0.72 | PG | Procter Gamble Earnings Call Today | PairCorr |
| 0.7 | UG | United Guardian | PairCorr |
| 0.83 | UL | Unilever PLC ADR Earnings Call This Week | PairCorr |
Moving against Clorox Stock
| 0.61 | NAII | Natural Alternatives | PairCorr |
| 0.56 | YSG | Yatsen Holding Financial Report 21st of May 2024 | PairCorr |
| 0.49 | PURE | Pure Bioscience | PairCorr |
The ability to find closely correlated positions to Clorox could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Clorox when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Clorox - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling The Clorox to buy it.
The correlation of Clorox is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Clorox moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Clorox moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Clorox can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in The Clorox. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for Clorox Stock analysis
When running Clorox's price analysis, check to measure Clorox's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clorox is operating at the current time. Most of Clorox's value examination focuses on studying past and present price action to predict the probability of Clorox's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clorox's price. Additionally, you may evaluate how the addition of Clorox to your portfolios can decrease your overall portfolio volatility.
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |
Is Clorox's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clorox. If investors know Clorox will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clorox listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Dividend Share 2.38 | Earnings Share 0.63 | Revenue Per Share 58.997 | Quarterly Revenue Growth 0.16 |
The market value of Clorox is measured differently than its book value, which is the value of Clorox that is recorded on the company's balance sheet. Investors also form their own opinion of Clorox's value that differs from its market value or its book value, called intrinsic value, which is Clorox's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clorox's market value can be influenced by many factors that don't directly affect Clorox's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clorox's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clorox is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clorox's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.